Summit Therapeutics

SMMT · NASDAQ

$16.09+$0.52 (+3.34%)TodayMarket closed ·
Prev close $15.57

Who owns SMMT

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 90.0% of SMMT’s shares.

  • Duggan (Robert William)71.9%
  • Zanganeh (Mahkam)4.5%
  • Baker Bros. Advisors LP4.1%
  • Xia (Yu)4.0%
  • Next 6 largest institutions5.4%
  • All other shareholders10.0%
Top institutional holders of SMMT
HolderShares% of shares
Duggan (Robert William)573.88M71.94%
Zanganeh (Mahkam)36.03M4.52%
Baker Bros. Advisors LP32.79M4.11%
Xia (Yu)32.06M4.02%
Fidelity Management & Research Company LLC10.04M1.26%
State Street Investment Management (US)9.54M1.20%
BlackRock Institutional Trust Company, N.A.7.57M0.95%
Vanguard Capital Management, LLC5.73M0.72%
UBS Financial Services, Inc.5.23M0.66%
Vanguard Portfolio Management, LLC5.04M0.63%

Largest mutual fund holders

Top mutual fund holders of SMMT
HolderShares% of shares
State Street SPDR S&P Biotech ETF7.85M0.98%
Vanguard Total Stock Market Index Fund3.73M0.47%
Vanguard Small-Cap Index Fund2.68M0.34%
Fidelity Growth Company Fund2.65M0.33%
T. Rowe Price Health Sciences Fund2.53M0.32%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $103.62M (6 trades) of SMMT on the open market, with no sales.

Latest SMMT insider transactions
InsiderTypeSharesValue
Anand BhaskarAward100.00K—
Zanganeh MahkamBuy3.81M$49.99M
DUGGAN ROBERT WBuy3.81M$49.99M
Soni Manmeet SinghBuy25.00K$360.75K
Soni Manmeet SinghBuy25.00K$361.50K
Zanganeh MahkamBuy100.00K$1.46M
DUGGAN ROBERT WBuy100.00K$1.46M

Short interest

Settled Sep 30, 2026

Shares short
41.16M
Days to cover
4.84
% of shares outstanding
5.16%
Average daily volume
8.50M
Change since last report
+0.2%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.